Literature DB >> 100416

Human triclonal anti-IgG gammopathy. I. Iso-electric focusing characteristics of the IgG, IgA and IgM anti-IgG and their heavy and light chains.

G N Abraham.   

Abstract

Human IgG, IgA and IgM anti-IgG autoantibodies have been isolated from the serum of an individual with Felty's syndrome. These were initially noted as soluble circulating serum complexes by analytical ultracentrifugation. Isolation was accomplished by solid phase immunoadsorption and each of the three antibody populations obtained was shown to be of restricted heterogeneity by liquid and polyacrylamide gel electrofocussing methods. Type kappa light chains were obtained from each protein. Co-isoelectric focusing experiments of all possible pairs of these light chains showed them to have identical net charge characteristics. Heavy chains obtained from each protein were also monoclonal and of differing isoelectric point. The availability of this serum provides a human model with which to study the changes which may occur in autoantibodies during the autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100416      PMCID: PMC1457633     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Characterization of a human macroglobulin. V. A Waldenström macroglobulin with antibody activity.

Authors:  H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

2.  On the distribution of rheumatoid factors among the immunoglobulins.

Authors:  R Heimer; F M Levin
Journal:  Immunochemistry       Date:  1966-01

3.  Studies on IgA and IgG monoclonal proteins derived from a single patient. I. Evidence for shared individually specific antigenic determinants.

Authors:  D S Fair; R G Krueger; G J Gleich; R A Kyle
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

4.  Evidence for a common synthetic origin for secretory and serum IgA.

Authors:  G N Abraham; E Santucci; R F Jacox
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

5.  Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM.

Authors:  Y Yagi; D Pressman
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

6.  Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin.

Authors:  G N Abraham; R A Clark; J H Vaughan
Journal:  Immunochemistry       Date:  1972-03

Review 7.  Hypergammaglobulinemic purpura. Studies on the unusual anti- -globulins characteristic of the sera of these patients.

Authors:  J D Capra; R J Winchester; H G Kunkel
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

8.  Felty's syndrome. A clinical and pathological survey of 21 patients and their response to treatment.

Authors:  C G Barnes; A L Turnbull; B Vernon-Roberts
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

9.  Sharing of individual antigenic determinants between a gamma G and a gamma M protein in the same myeloma serum.

Authors:  G M Penn; H G Kunkel; H M Grey
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

10.  Reversal of systemic manifestations of cryoglobulinemia. Treatment with melphalan and prednisone.

Authors:  S C Ristow; P F Griner; G N Abraham; I Shoulson
Journal:  Arch Intern Med       Date:  1976-04
View more
  3 in total

1.  Immunological and structural properties of human monoclonal IgG cryoglobulins.

Authors:  G N Abraham; D N Podell; R Wistar; S L johnston; E H Welch
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  Human triclonal anti-IgG gammopathy. II. Determination of the antigenic specificity patterns of the IgG, IgA and IgM autoantibodies for the subclasses of IgG.

Authors:  G N Abraham; E Welch; H W Trieshmann
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

3.  Spectrotypic analysis of IgM and IgA rheumatoid factors.

Authors:  J L Chu; A E Gharavi; K B Elkon
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.